Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:
Find out more about our cookies policy
(+1) 617 896 0213
info@sagentia.com
Following reports that Roche Holding AG may have agreed to buy Illumina, Inc., the US maker of DNA sequencing equipment, Sagentia's Diagnostics Instrumentation Consultant, Nick Rolllings, comments on the impact of the deal on the DNA sequencing sector. » Read more
Tags: Roche, Illumina, acquisition, DNA sequencing
Sagentia's Head of Intellectual Property Services, Mark Cohen, comments on the advent of a new european single patent system, as reported in the Financial Times. » Read more
Tags: patents, IP, europe
Following the announcement by 23andme, Inc. of a $99 Personal Genome Service, Matt Chandler, Sagentia's Diagnostics Sector Specialist, comments on the rapid pace of development in genomic medicine. » Read more
Tags: genetic sequence, genome, companion diagnostics, DNA
The European Commission has released new proposals for regulations on medical and in vitro diagnostic devices that look set to replace the longstanding European directives. Here are a few comments from us on what impact these changes could actually have. » Read more
LED technology celebrates its 50th anniversary this month. First demonstrated by a GE employee Nick Holonyak, Jr. on October 9th 1962, LEDs have become a core light component used in a broad range of applications, from simple consumer electronics UIs through to advanced medical devices. » Read more
Tags: LED. lighting
Keep track of site upates using our RSS feeds, click a link below to view the feed.